Bridgewater Advisors Inc. Lowers Holdings in Merck & Co., Inc. (NYSE:MRK)

Bridgewater Advisors Inc. lowered its holdings in Merck & Co., Inc. (NYSE:MRK – Get Rating) by 26.4% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,954 shares of the company’s stock after selling 5,363 shares during the period. Bridgewater Advisors Inc.’s holdings in Merck & Co., […]

Related Keywords

Steven Mizell ,Societe Generale ,Sanat Chattopadhyay ,Tradewinds Capital Management ,Merck Co Inc ,Bridgewater Advisors Inc ,Credit Suisse Group ,Quarter For Merck Co Inc ,O Keefe Stevens Advisory Inc ,Mcrae Capital Management Inc ,Animal Health ,Capital Advantage Inc ,Jpmorgan Chase Co ,Group Wealth Management ,Securities Exchange Commission ,News Ratings For Merck Co ,Merck Co ,Okeefe Stevens Advisory Inc ,Bridgewater Advisors ,Get Rating ,Capital Management ,Wealth Management ,Keefe Stevens Advisory ,Suisse Group ,Exchange Commission ,Visit Holdingschannel ,Nyse Mrk ,Mrk ,Medical ,58933y10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,